UI Hospitals and Clinics

Studies | Researchers

Clinical Research

Showing newest first. Show oldest first. Or order by title

  1. A Phase 3, Randomized, Open-Label Study of Nivolumab Combined with Ipilimumab Versus Sunitinib Monotherapy in Subjects with Previously Untreated, Advanced or Metastatic Renal Cell Carcinoma
    Daniel Vaena
  2. Preoperative Assessment and Post-Operative Outcomes of Elderly Women with Gynecologic Cancers
    David Bender
  3. Quantitative Assessment of Minimal Detectable Disease in N0 and N1 Head and Neck Cancers
    John Sunderland
  4. A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Azacitidine with or without Birinapant with a Single Arm Open-Label Run-In Phase in Subjects with Higher Risk Myelodysplastic Syndrome…
    Rupali Roy
  5. Phase 2 Efficacy and Safety Study of Intravenous GPX-150, an Anthracycline Analog, in Patients with Soft Tissue Sarcoma
    Mohammed Milhem
  6. A Randomized Controlled Phase 3 Study of Oral Pacritinib versus Best Available Therapy in Patients with Thrombocytopenia and Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essent…
    Usha Perepu
  7. Phase 1 / Comparative Randomized Phase II Trial of TRC105 + Bevacizumab vs Bevacizumab in Bevacizumab-Naive Patients with Recurrent Glioblastoma Multiforme
    Mohammed Milhem
  8. A Phase 1, First-in-Human, Single-Dose, Open-label, Positron Emission Tomography(PET) Imaging Study of [68Ga]MLN6907 in Patients with Metastatic Colorectal Carcinoma
    Daniel Berg
  9. An Open Label, Randomized (2:1) Phase IIb Study of Dasatinib Versus Imatinib in Patients With Chronic Phase Chronic Myeloid Leukemia Who Have Not Achieved an Optimal Response to 3 Months of Therapy Wi…
    Usha Perepu
  10. A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Docetaxel in Combination with 1-m(1)
    Alexandra Thomas
  11. A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABF(1)
    Ayman El-Sheikh
  12. Interactionality of State-Trait Music Preference, Individual Variability, and Music Characteristics as a Multi-Axis Paradigm for Context-Specific Pain Perception and Management
    Xueli Tan
  13. Phase I/II Study of the Concomitant Administration of Indoximod Plus Ipilimumab for Adult Patients with Metastatic Melanoma
    Yousef Zakharia
  14. Modular Phase II Study to Link Targeted Therapy to Patients With Pathway Activated Tumors: Module 3 - MEK162 for Patients With RAS/RAF/MEK Activated Tumors
    Daniel Vaena
  15. A Randomised, Double-Blind, Parallel Group, Placebo-controlled Multi-Centre Phase III Study to Assess the Efficacy and Safety of Olaparib Versus Placebo as Adjuvant Treatment in Patients with Germline…
    Alexandra Thomas
  16. Longitudinal Assessment of Ovarian Reserve in Adolescents with Lymphoma
    Ayman El-Sheikh
  17. A Phase 3, Randomized, Placebo-controlled, Multicenter, Double-blind Study to Evaluate the Safety and Efficacy of Telotristat Etiprate (LX1606)...
    Joseph Dillon
  18. A Phase 1, First-in-Human, Single-Dose, Open-Label, Positron Emission Tomography (PET) Imaging Study of [68Ga]MLN6907 in Patients With...
    Daniel Berg
  19. A Phase II Double-Blinded, Randomized, Placebo-Controlled Study of Docetaxel in Combination with 1-methyl-D-tryptophan (indoximod) in Metastatic Breast Cancer
    Alexandra Thomas
  20. A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T- Lymphoblastic Lymphoma (T-LLy…
    Ayman El-Sheikh

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.